Criteria for the choice and definition of healthy volunteers and or patients for phase I and phase II studies in drug development. Commentary on an action for cooperative research. [electronic resource]
- European journal of clinical pharmacology 1989
- 549-50 p. digital
Publication Type: Journal Article
0031-6970
10.1007/BF00637733 doi
Drug Evaluation Europe Humans International Cooperation Pharmacogenetics Polymorphism, Genetic